Cargando…
Life-threatening Hyperkalemia Associated with Axitinib Treatment in Patients with Recurrent Renal Carcinoma
Axitinib has emerged as a promising antineoplastic agent for the treatment of advanced renal cell carcinoma. Although the administration of axitinib was well-tolerated in clinical trials, the real-world safety and tolerability remain unverified. We herein report a patient with metastatic renal cell...
Autores principales: | Godo, Shigeo, Yoshida, Yoshitaro, Kawamorita, Naoki, Mitsuzuka, Koji, Kawazoe, Yu, Fujita, Motoo, Kudo, Daisuke, Nomura, Ryosuke, Shimokawa, Hiroaki, Kushimoto, Shigeki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207819/ https://www.ncbi.nlm.nih.gov/pubmed/29780111 http://dx.doi.org/10.2169/internalmedicine.0262-17 |
Ejemplares similares
-
The Dramatic Recovery of a Patient with Biguanide-associated Severe Lactic Acidosis Following Thiamine Supplementation
por: Godo, Shigeo, et al.
Publicado: (2017) -
Switching Therapy from Intravenous Landiolol to Transdermal Bisoprolol in a Patient with Thyroid Storm Complicated by Decompensated Heart Failure and Gastrointestinal Dysfunction
por: Godo, Shigeo, et al.
Publicado: (2017) -
Permissive hypotension/hypotensive resuscitation and restricted/controlled resuscitation in patients with severe trauma
por: Kudo, Daisuke, et al.
Publicado: (2017) -
Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report
por: Katsumata, Yuki, et al.
Publicado: (2021) -
Acute traumatic coagulopathy and trauma-induced coagulopathy: an overview
por: Kushimoto, Shigeki, et al.
Publicado: (2017)